1. Current Status, Position
Dr Paul Cornes (BM BCH MA MRCP FRCR) is an Oncologist from Bristol, UK.
Dr Paul Cornes trained in Medicine at Oxford University and in Oncology at the Royal Marsden Hospital, London, UK before becoming a Consultant Oncologist in Bristol, UK.
3. Research Area
Dr Paul Cornes is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment. He was part of the team that developed and presented evidence to the Oncology Advisory drugs Committee of the FDA for the first successfully approved US biosimilar. He has been in the British Medical Journal's "Round Table" group on Biosimilars and has been on the panel for the EU Commission biosimilars meeting in Brussels.
4. Conflict of interest: Dr Paul Cornes received honoraria from the following companies for speaking at meetings in 2017: Astro, Biogen and Medicines for Europe/Europen Generics Association. He receives speaker honoraria from Napp and Pfizer/Hospira.